|
FOXK1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.419430E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.696600E-03 |
| Normal-vs-Stage2 |
8.247700E-02 |
| Normal-vs-Stage3 |
1.278150E-02 |
| Normal-vs-Stage4 |
6.600200E-03 |
| Stage1-vs-Stage2 |
7.606800E-01 |
| Stage1-vs-Stage3 |
9.689000E-01 |
| Stage1-vs-Stage4 |
3.030200E-01 |
| Stage2-vs-Stage3 |
7.588200E-01 |
| Stage2-vs-Stage4 |
3.101400E-01 |
| Stage3-vs-Stage4 |
3.712800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.164480E-03 |
| Normal-vs-AfricanAmerican |
7.018200E-01 |
| Normal-vs-Asian |
7.442500E-04 |
| Caucasian-vs-AfricanAmerican |
1.942230E-01 |
| Caucasian-vs-Asian |
5.751800E-02 |
| AfricanAmerican-vs-Asian |
5.362000E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.999470E-04 |
| Normal-vs-Female |
1.022160E-02 |
| Male-vs-Female |
2.114100E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.440000E-03 |
| Normal-vs-Age(41-60Yrs) |
2.875800E-03 |
| Normal-vs-Age(61-80Yrs) |
9.969900E-02 |
| Normal-vs-Age(81-100Yrs) |
8.822300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.188200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.467000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.662000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.829400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.447800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.441000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.306800E-01 |
| Classical-VS-Follicular |
2.1262999999605E-06 |
| Classical-VS-Other |
9.845200E-01 |
| Classical-VS-Normal |
3.81210000000021E-05 |
| Tall-VS-Follicular |
1.021550E-02 |
| Tall-VS-Other |
9.847000E-01 |
| Tall-VS-Normal |
2.860400E-02 |
| Follicular-VS-Other |
1.544170E-01 |
| Follicular-VS-Normal |
7.307800E-01 |
| Other-VS-Normal |
3.520200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.689730E-02 |
| Normal-vs-N1 |
4.036600E-03 |
| N0-vs-N1 |
2.419600E-01 |
|
|
